White label ELPA - ClinicalTrials.eu

Study on the Long-term Safety and Effectiveness of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Not recruiting

3 1 1
Investigated diseases:
- Dermatitis atopic
Investigated drugs:
- Lebrikizumab
Study on Ketotifen Eye Drops for Treating Seasonal Allergic Conjunctivitis in Patients

Not recruiting

3 1 1
Investigated diseases:
- Conjunctivitis allergic
Investigated drugs:
- Ketotifen Hydrogen Fumarate
Study on the Safety and Effectiveness of Olanzapine for Patients with Schizophrenia

Not recruiting

3 1 1 1
Investigated diseases:
- Schizoaffective disorder
- Schizophrenia
Investigated drugs:
- Olanzapine
Study on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations

Not recruiting

3 1
Investigated diseases:
- Chronic obstructive pulmonary disease
Investigated drugs:
- Benralizumab
+7
Study on AUP1602-C for Treating Non-Healing Diabetic Foot Ulcers in Patients

Not recruiting

2 1
Investigated diseases:
- Diabetic foot
Investigated drugs:
- Aup1602-C
Study on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Not recruiting

3 1
Investigated diseases:
- Hidradenitis
+3
Study on Nivolumab for Preventing Melanoma Recurrence in Patients with Completely Removed Stage IIB/C Melanoma

Not recruiting

3 1 1
Investigated diseases:
- Malignant melanoma
Investigated drugs:
- Nivolumab
+9
Study on Azacitidine and Gilteritinib for Adults with Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

Not recruiting

2 1 1 1
Investigated diseases:
- Acute myeloid leukaemia
Investigated drugs:
- Gilteritinib
- Azacitidine
Continued Treatment Study for Patients with Myelofibrosis, Post-Lung Transplant BOS, or Chronic Graft-Versus-Host Disease Using Itacitinib

Not recruiting

2 1 1
Investigated diseases:
- Chronic graft versus host disease
- Myelofibrosis
Investigated drugs:
- Itacitinib
Study of 68Ga Satoreotide Trizoxetan PET/CT in Patients with High-Grade Neuroendocrine Lung Cancer

Not recruiting

2 1 1
Investigated diseases:
- Neuroendocrine tumour of the lung
Investigated drugs:
- Satoreotide Trizoxetan Gallium Ga-68

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies